Interleukin-10 is expressed in HepG2.2.15 cells and regulated by STAT1 pathway

Abstract

This study investigated the expression profiles of IL-10 gene in three human hepatoma cell lines including Huh7, HepG2, and HepG2 transfected with a plasmid containing hepatitis B virus (HBV) named HepG2.2.15. RT-PCR analysis demonstrated that IL-10 message RNA was absent in HepG2 and Huh7 cells, whereas it was present in HepG2.2.15 cells, which was consistent with ELISA result. Furthermore, except for lamivudine other antiviral treatments did not significantly decrease the HBV DNA level in HepG2.2.15 cells, while they had different effects on the expression of IL-10 protein, although stimulation by LPS had no significant effect. In addition, except for poly(I:C), the other treatments decreased the expression of IL-10 protein to different degrees, but had no significant effects on the expression of NF-κB and MyD88. Meanwhile, all treatments we used had effect on the expression of STAT1. In conclusion, IL-10 was expressed in HepG2.2.15 cells and STAT1 pathway might be involved in the regulation of IL-10 expression in HepG2.2.15 cells, but it was not the sole pathway, the exact mechanism warrants further study.

Keywords

hepatoma cell / interleukin-10 / hepatitis B virus / hepatocyte / HepG2.2.15

References

[1] CavanaughV.J., GuidottiL.G., ChisariF.V.. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol, 1997, 71(4): 3236-3243

[2] KimuraK., KakimiK., WielandS., et al.. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol, 2002, 76(21): 10702-10707

[3] SuriD., SchillingR., LopesA.R., et al.. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J Hepatol, 2001, 35(6): 790-797

[4] WuJ.F., WuT.C., ChenC.H., et al.. Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology, 2010, 138(1): 165-72

[5] BaiF., TownT., QianF., et al.. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog, 2009, 5(10): e1000610

[6] BlackburnS.D., WherryE.J.. IL-10, T cell exhaustion and viral persistence. Trends Microbiol, 2007, 5(4): 143-146

[7] BrooksD.G., TrifiloM.J., EdelmannK.H., et al.. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med, 2006, 12(11): 1301-1309

[8] MarisC.H., ChappellC.P., JacobJ.. Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunol, 2007, 8: 8

[9] MosserD.M., ZhangX.. Interleukin-10: new perspectives on an old cytokine. Immunol Rev, 2008, 226: 205-218

[10] SaraivaM., O’GarraA.. The regulation of IL-10 production by immune cells. Nat Rev Immunol, 2010, 10(3): 170-181

[11] LouisH., Van LaethemJ.L., WuW., et al.. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology, 1998, 28(6): 1607-1615

[12] ThompsonK., MaltbyJ., FallowfieldJ., et al.. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology, 1998, 28(6): 1597-1606

[13] TsukamotoH.. Is interleukin-10 antifibrogenic in chronic liver injury?. Hepatology, 1998, 28(6): 1707-1709

[14] WarrenA., Le CouteurD.G., FraserR., et al.. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology, 2006, 44(5): 1182-1190

[15] HerkelJ., JagemannB., WiegardC., et al.. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes. Hepatology, 2003, 37(5): 1079-1085

[16] MuhlbauerM., FleckM., SchutzC., et al.. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol, 2006, 45(4): 520-528

[17] WiegardC., WolintP., FrenzelC., et al.. Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance. Gastroentero logy, 2007, 133(6): 2010-2018

[18] SharpeA.H., WherryE.J., AhmedR., et al.. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol, 2007, 8(3): 239-245

[19] SellsM.A., ChenM.L., AcsG.. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA, 1987, 84(4): 1005-1009

[20] PreissS., ThompsonA., ChenX., et al.. Characterization of the innate immune signalling pathways in hepatocyte cell lines. J Viral Hepat, 2008, 15(12): 888-900

[21] LiuJ., YangY., HuB., et al.. Development of HBsAgbinding aptamers that bind HepG2.2.15 cells via HBV surface antigen. Virol Sin, 2010, 25(1): 27-35

[22] ChenY., WuW., LiL.J., et al.. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta, 2006, 372(1–2): 129-133

[23] LeiY.C., HaoY.H., ZhangZ.M., et al.. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo. World J Gastroenterol, 2006, 12(28): 4492-4497

[24] AmanM.J., TretterT., EisenbeisI., et al.. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood, 1996, 87(11): 4731-4736

[25] OzenciV., KouwenhovenM., HuangY.M., et al.. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol, 2000, 120(1): 147-153

[26] Ziegler-HeitbrockL., LotzerichM., SchaeferA., et al.. IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J Immunol, 2003, 171(1): 285-290

[27] MoriN., PragerD.. Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: identification and characterization of NF-kappa B binding sites in the regulatory region of the interleukin-10 gene. Eur J Haematol, 1997, 59(3): 162-170

[28] BondesonJ., BrowneK.A., BrennanF.M., et al.. Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cy-tokines are inhibited, but IL-10 is nuclear factor-kappaB independent. J Immunol, 1999, 162(5): 2939-2945

[29] BattenM., KljavinN.M., LiJ., et al.. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol, 2008, 180(5): 2752-2756

[30] KallioliasG.D., IvashkivL.B.. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol, 2008, 180(9): 6325-6333